Oncovin and Drug level increased - a phase IV clinical study of FDA data

Summary:

Drug level increased is reported as a side effect among people who take Oncovin (vincristine sulfate), especially for people who are male, 20-29 old, have been taking the drug for < 1 month also take Micafungin, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Drug level increased when taking Oncovin. It is created by eHealthMe based on reports of 6,660 people who have side effects when taking Oncovin from the FDA, and is updated regularly.

What is Oncovin?

Oncovin has active ingredients of vincristine sulfate. eHealthMe is studying from 6,667 Oncovin users. Check the latest studies of Oncovin.

What is Drug level increased?

Drug level increased is found to be associated with 874 drugs and 1,136 conditions by eHealthMe. Check the latest studies of Drug level increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

6,660 people reported to have side effects when taking Oncovin.
Among them, 13 people (0.2%) have Drug level increased.

Could Oncovin cause Drug level increased?

Among these 13 people:

How long have people been on Oncovin when they have Drug level increased? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Drug level increased when taking Oncovin? *

  • female: 9.09 %
  • male: 90.91 %

What is the age of people who have Drug level increased when taking Oncovin? *

  • 0-1: 0.0 %
  • 2-9: 18.18 %
  • 10-19: 27.27 %
  • 20-29: 27.27 %
  • 30-39: 0.0 %
  • 40-49: 18.18 %
  • 50-59: 0.0 %
  • 60+: 9.09 %

What are other drugs people take besides Oncovin? *

  1. Fluconazole: 3 people, 23.08%
  2. Amphotericin B: 3 people, 23.08%
  3. Vfend: 3 people, 23.08%
  4. Noxafil: 3 people, 23.08%
  5. Micafungin: 3 people, 23.08%
  6. Glivec: 2 people, 15.38%
  7. Methotrexate: 2 people, 15.38%
  8. Purinethol: 2 people, 15.38%
  9. Pantoprazole: 2 people, 15.38%
  10. Cyclophosphamide: 2 people, 15.38%

What are other side effects people have besides Drug level increased? *

  1. Headache (pain in head): 3 people, 23.08%
  2. Intestinal Obstruction: 3 people, 23.08%
  3. Hallucinations (sensations that appear real but are created by your mind): 3 people, 23.08%
  4. Drowsiness: 3 people, 23.08%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 23.08%
  6. Inappropriate Antidiuretic Hormone Secretion: 3 people, 23.08%
  7. Hallucination, Auditory (perceiving sounds without auditory stimulus): 3 people, 23.08%
  8. Acute Kidney Failure: 3 people, 23.08%
  9. Pain: 2 people, 15.38%
  10. Hepatic Function Abnormal: 2 people, 15.38%

What are the existing conditions these people have? *

  1. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 30.77%
  2. Fungal Infection: 3 people, 23.08%
  3. Precursor T-Lymphoblastic Lymphoma/leukaemia (precursor b-cell cancer): 1 person, 7.69%
  4. Pneumonia: 1 person, 7.69%
  5. Osteosarcoma (a cancerous (malignant) bone tumour): 1 person, 7.69%
  6. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 7.69%
  7. Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 1 person, 7.69%
  8. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 1 person, 7.69%
  9. Infection: 1 person, 7.69%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Oncovin and have Drug level increased?

- Check whether Drug level increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oncovin:

Drug level increased treatments and more:

How severe was Drug level increased and when was it recovered:

Expand to all the drugs that have ingredients of vincristine sulfate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Oncovin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drug level increased:

Browse all the conditions that are associated with Drug level increased:


How the study uses the data?

The study uses data from the FDA. It is based on vincristine sulfate (the active ingredients of Oncovin) and Oncovin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: